Target intelligence / Profile preview

Bacterial cell wall and cytoplasmic membrane

Molecular classification
Cellular structural component, Biological barrier
01

Overview

The bacterial cell wall and cytoplasmic membrane are fundamental structures that maintain the integrity and viability of bacterial cells. The cell wall, characterized by its peptidoglycan content, provides mechanical strength to withstand high internal osmotic pressure, while the underlying cytoplasmic membrane acts as a selective barrier for nutrient transport and energy production [1][3]. These components are primary targets for many classes of antibiotics because their unique composition—such as the presence of D-amino acids in peptidoglycan—allows for selective toxicity against pathogens without harming eukaryotic host cells [2]. Beta-lactam antibiotics and glycopeptides interfere with the assembly and cross-linking of the peptidoglycan layer, leading to osmotic lysis and cell death. Meanwhile, lipopeptides and polymyxins target the cytoplasmic membrane, causing depolarization or physical disruption that results in the leakage of essential intracellular contents [3][4]. These targets are central to the treatment of diverse bacterial infections, ranging from skin infections to life-threatening sepsis. However, the clinical utility of drugs hitting these targets is increasingly threatened by the evolution of complex bacterial resistance mechanisms, such as modified penicillin-binding proteins or altered membrane charges [1].

Other names
Bacterial cell envelopePeptidoglycan layerBacterial plasma membraneBacterial envelope
02

Mechanism of action

Inhibition of peptidoglycan synthesis via binding to penicillin-binding proteins (PBPs) or lipid precursors, and disruption of membrane potential or physical integrity [1][2][4].

03

Biological functions

Structural integrityOsmotic protectionSelective permeabilityCell divisionNutrient transport
04

Disease associations

Bacterial infectionSepsisPneumoniaMeningitisUrinary tract infection
05

Safety considerations

Development of antimicrobial resistanceNephrotoxicityOtotoxicityHypersensitivity reactionsDisruption of commensal microbiota
06

Interacting drugs

Amoxicillin

6 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)ProcalcitoninC-reactive protein (CRP)

Beyond the preview

Go deeper on Bacterial cell wall and cytoplasmic membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial cell wall and cytoplasmic membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call